John A. Altin

709 total citations
20 papers, 262 citations indexed

About

John A. Altin is a scholar working on Immunology, Infectious Diseases and Epidemiology. According to data from OpenAlex, John A. Altin has authored 20 papers receiving a total of 262 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 6 papers in Infectious Diseases and 5 papers in Epidemiology. Recurrent topics in John A. Altin's work include T-cell and B-cell Immunology (9 papers), Immune Cell Function and Interaction (7 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). John A. Altin is often cited by papers focused on T-cell and B-cell Immunology (9 papers), Immune Cell Function and Interaction (7 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). John A. Altin collaborates with scholars based in United States, Australia and Belgium. John A. Altin's co-authors include Christopher C. Goodnow, Adrian Liston, Matthew Cook, Lei Tian, Chong Shen, Edward M. Bertram, James Dooley, Lydia Makaroff, Dean Franckaert and Charis E. Teh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Blood.

In The Last Decade

John A. Altin

16 papers receiving 262 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John A. Altin United States 9 170 55 33 29 25 20 262
Selvakumar Sukumar United States 8 324 1.9× 57 1.0× 25 0.8× 22 0.8× 39 1.6× 9 413
Ileana Licona‐Limón Mexico 7 200 1.2× 41 0.7× 51 1.5× 17 0.6× 39 1.6× 8 286
Megan M. Eva Canada 7 276 1.6× 62 1.1× 72 2.2× 30 1.0× 19 0.8× 7 382
Shirley Helm United States 8 206 1.2× 35 0.6× 30 0.9× 17 0.6× 18 0.7× 13 325
Shangguo Tang Canada 9 88 0.5× 30 0.5× 18 0.5× 14 0.5× 31 1.2× 14 261
Helena M. Izquierdo Spain 5 243 1.4× 79 1.4× 33 1.0× 15 0.5× 29 1.2× 5 315
Salem Al‐Tamemi Oman 10 112 0.7× 55 1.0× 29 0.9× 32 1.1× 9 0.4× 33 222
Carolyn E. Rydyznski United States 6 278 1.6× 35 0.6× 17 0.5× 55 1.9× 33 1.3× 9 370
Fatma Doener Germany 5 115 0.7× 91 1.7× 33 1.0× 45 1.6× 14 0.6× 5 189
Darina Spasova United States 6 185 1.1× 75 1.4× 25 0.8× 48 1.7× 33 1.3× 7 287

Countries citing papers authored by John A. Altin

Since Specialization
Citations

This map shows the geographic impact of John A. Altin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Altin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Altin more than expected).

Fields of papers citing papers by John A. Altin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Altin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Altin. The network helps show where John A. Altin may publish in the future.

Co-authorship network of co-authors of John A. Altin

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Altin. A scholar is included among the top collaborators of John A. Altin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Altin. John A. Altin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kala, Mrinalini, Erin Kelley, John A. Altin, et al.. (2025). Identification of Coccidioidomycosis Immunoreactive Peptides That Recall T-Cell Responses Indicating Past Exposure. The Journal of Infectious Diseases. 231(6). 1619–1628.
2.
Elko, Evan A., Charles H. D. Williamson, Heather Mead, et al.. (2025). PepSeq as a highly multiplexed platform for melioidosis antigen discovery and vaccine development. Frontiers in Immunology. 16. 1605758–1605758.
3.
Elko, Evan A., et al.. (2024). Recurrent SARS-CoV-2 mutations at Spike D796 evade antibodies from pre-Omicron convalescent and vaccinated subjects. Microbiology Spectrum. 12(2). e0329123–e0329123. 6 indexed citations
4.
Elko, Evan A., et al.. (2024). Mapping disparities in viral infection rates using highly multiplexed serology. mSphere. 9(9). e0012724–e0012724. 1 indexed citations
5.
Chung, Vincent, Raffaella Soldi, Paul P. Huang, et al.. (2024). 681 Clinical development of STL-101, a personalized TIL therapy for treatment of advance solid tumors. Regular and Young Investigator Award Abstracts. A781–A781.
6.
Mead, Heather, Irene Ruberto, John A. Altin, et al.. (2023). “Sniffing” out SARS-CoV-2 in Arizona working dogs: an exploratory serosurvey. Frontiers in Veterinary Science. 10. 1166101–1166101. 3 indexed citations
7.
Kelley, Erin, Anna Engelbrektson, Heather Mead, et al.. (2023). Virome-wide detection of natural infection events and the associated antibody dynamics using longitudinal highly-multiplexed serology. Nature Communications. 14(1). 1783–1783. 13 indexed citations
8.
Elko, Evan A., Yong Liang, Anna Engelbrektson, et al.. (2022). PepSeq: a fully in vitro platform for highly multiplexed serology using customizable DNA-barcoded peptide libraries. Nature Protocols. 18(2). 396–423. 16 indexed citations
9.
Agudelo‐Flórez, Piedad, et al.. (2022). Highly Multiplexed Serology for Nonhuman Mammals. Microbiology Spectrum. 10(5). e0287322–e0287322. 3 indexed citations
10.
Kelley, Erin, Sandra Zurawski, Heather Mead, et al.. (2021). A Framework to Identify Antigen-Expanded T Cell Receptor Clusters Within Complex Repertoires. Frontiers in Immunology. 12. 735584–735584. 2 indexed citations
11.
Altin, John A., et al.. (2021). Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses. The Journal of Immunology. 206(1_Supplement). 114.10–114.10. 8 indexed citations
12.
Ogongo, Paul, et al.. (2020). Single cell transcriptomics of the T cell response to Mycobacterium Tuberculosis reveals phenotypic diversity within and between infected individuals. The Journal of Immunology. 204(1_Supplement). 225.21–225.21. 2 indexed citations
13.
Altin, John A., Stephen R. Daley, Jason Howitt, et al.. (2014). Ndfip1 mediates peripheral tolerance to self and exogenous antigen by inducing cell cycle exit in responding CD4+T cells. Proceedings of the National Academy of Sciences. 111(6). 2067–2074. 20 indexed citations
14.
Altin, John A., Christopher C. Goodnow, & Matthew Cook. (2012). IL-10+CTLA-4+ Th2 Inhibitory Cells Form in a Foxp3-Independent, IL-2–Dependent Manner from Th2 Effectors during Chronic Inflammation. The Journal of Immunology. 188(11). 5478–5488. 15 indexed citations
15.
Enders, Anselm, Sanda Stankovic, Charis E. Teh, et al.. (2012). ZBTB7B (Th-POK) Regulates the Development of IL-17–Producing CD1d-Restricted Mouse NKT Cells. The Journal of Immunology. 189(11). 5240–5249. 36 indexed citations
16.
Altin, John A., Lei Tian, Adrian Liston, et al.. (2011). Decreased T-cell receptor signaling through CARD11 differentially compromises forkhead box protein 3–positive regulatory versus TH2 effector cells to cause allergy. Journal of Allergy and Clinical Immunology. 127(5). 1277–1285.e5. 44 indexed citations
17.
Hoyne, Gerard F., Mehmet Yabas, Charis E. Teh, et al.. (2011). Visualizing the Role of Cbl-b in Control of Islet-Reactive CD4 T Cells and Susceptibility to Type 1 Diabetes. The Journal of Immunology. 186(4). 2024–2032. 19 indexed citations
18.
Tian, Lei, John A. Altin, Lydia Makaroff, et al.. (2011). Foxp3+ regulatory T cells exert asymmetric control over murine helper responses by inducing Th2 cell apoptosis. Blood. 118(7). 1845–1853. 49 indexed citations
19.
Altin, John A., Chong Shen, & Adrian Liston. (2010). Understanding the genetic regulation of IgE production. Blood Reviews. 24(4-5). 163–169. 25 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026